TrialAntimicrobial agents and chemotherapy2017

In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens.

Gregory G Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.